Clinical significance of topoisomerase‐II expression in patients with advanced non‐small cell lung cancer treated with amrubicin-Reference-Cited by-同舟云学术

Clinical significance of topoisomerase‐II expression in patients with advanced non‐small cell lung cancer treated with amrubicin

Author:

Sakurai Reiko¹,Kaira Kyoichi²^ORCID,Miura Yosuke³,Sunaga Noriaki³,Saito Ryusei⁴,Oyama Tetsunari⁵,Hisada Takeshi⁶,Yamada Masanobu¹

Affiliation:

1. Department of Medicine and Molecular ScienceGunma University Graduate School of Medicine Maebashi Japan

2. Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical CenterSaitama Medical University Hidaka Japan

3. Division of Allergy and Respiratory Medicine, Integrative Center of Internal MedicineGunma University Hospital Maebashi Japan

4. Departments of Respiratory Medicine, National Hospital Organization Shibukawa Medical Center Shibukawa Japan

5. Department of Diagnostic PathologyGunma University Graduate School of Medicine Maebashi Japan

6. Gunma University Graduate School of Health Science Maebashi Japan

Funder

Gunma University

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

Reference43 articles.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献